Polymorphisms in Genes That Regulate Cyclosporine Metabolism Affect Cyclosporine Blood Levels and Clinical Outcomes in Patients Who Receive Allogeneic Hematopoietic Stem Cell Transplantation-Reference-Cited by-同舟云学术

Polymorphisms in Genes That Regulate Cyclosporine Metabolism Affect Cyclosporine Blood Levels and Clinical Outcomes in Patients Who Receive Allogeneic Hematopoietic Stem Cell Transplantation

Published:2012-01 Issue:1 Volume:18 Page:37-43
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Koh Youngil,Kim Inho,Shin Dong-Yeop,Bae Ji-Yeon,Kim Hyun-Kyung,Yoon Sung-Soo,Park Sung Sup,Lee Dong Soon,Park Seonyang,Kim Byung Kook

Funder

Seoul National University Hospital Research Fund

Ministry of Health & Welfare, Republic of Korea

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference22 articles.

1. Cyclosporine concentration determinations for monitoring and pharmacokinetic studies;Ptachcinski;J Clin Pharmacol,1986

2. Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report;Iwatsuki;Transplant Proc,1988

3. The effect of CYP3A5 and MDR1 polymorphic expression on cyclosporine oral disposition in renal transplant patients;Yates;J Clin Pharmacol,2003

4. Clinical impact of polymorphisms of transport proteins and enzymes involved in the metabolism of immunosuppressive drugs;Rosso Felipe;Transplant Proc,2009

5. The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein;Zhang;Clin Pharmacokinet,2001

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of candidate genetic polymorphisms in the interaction between voriconazole and cyclosporine in patients undergoing allogeneic hematopoietic cell transplantation: An explorative study;Current Research in Translational Medicine;2020-04

2. Replication and validation of genetic polymorphisms associated with survival after allogeneic blood or marrow transplant;Blood;2017-09-28

3. Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Immunosuppressants in Allogeneic Hematopoietic Cell Transplantation: Part II;Clinical Pharmacokinetics;2015-11-30

4. Pharmacokinetics, Pharmacodynamics and Pharmacogenomics of Immunosuppressants in Allogeneic Haematopoietic Cell Transplantation: Part I;Clinical Pharmacokinetics;2015-11-13

5. Identification and Utilization of Donor and Recipient Genetic Variants to Predict Survival After HCT: Are We Ready for Primetime?;Current Hematologic Malignancy Reports;2015-02-21